Litcius/Paper detail

Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies

Lin Cheng, Shuo Song, Qing Fan, Senlin Shen, Haiyan Wang, Bing Zhou, Xiangyang Ge, Bin Ju, Zheng Zhang

2021Cell Discovery25 citationsDOIOpen Access PDF

Topics & Concepts

VirologyMonoclonal antibodyKappaSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)NeutralizationCoronavirus disease 2019 (COVID-19)Antibody2019-20 coronavirus outbreakMedicineImmunologyBiologyVirusOutbreakInfectious disease (medical specialty)Internal medicineDiseaseLinguisticsPhilosophySARS-CoV-2 and COVID-19 ResearchAnimal Virus Infections StudiesCOVID-19 Clinical Research Studies
Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies | Litcius